Informationen:
Fehler:
ID
25154
Beschreibung
AMC-053 Off-Study Summary Form (F50) Bortezomib, Ifosfamide, Carboplatin, and Etoposide, With or Without Rituximab, in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin Lymphoma Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=8B708D70-669B-F9DE-E040-BB89AD43114E
Link
Stichworte
Versionen (2)
- 19.09.12 19.09.12 -
- 28.08.17 28.08.17 -
Hochgeladen am
28. August 2017
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY-NC 3.0 Legacy
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
AMC-053 Off-Study Summary Form (F50)
Please submit this form if the subject has (at least one of the following): 1) completed the post treatment follow-up period per protocol 2) been lost to follow-up 3) has refused follow-up 4) withdrew consent 5) has died. (Note: If all follow-up for a subject has been completed, all subjects (except those never initiating protocol therapy) must have both an Off Protocol Treatment Summary form and Off Study Summary form submitted.)
- StudyEvent: AMC-053 Off-Study Summary Form (F50)
Ähnliche Modelle
Please submit this form if the subject has (at least one of the following): 1) completed the post treatment follow-up period per protocol 2) been lost to follow-up 3) has refused follow-up 4) withdrew consent 5) has died. (Note: If all follow-up for a subject has been completed, all subjects (except those never initiating protocol therapy) must have both an Off Protocol Treatment Summary form and Off Study Summary form submitted.)
- StudyEvent: AMC-053 Off-Study Summary Form (F50)
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
Ccrr Module For Off Study Summary - Rf50
C1518546 (UMLS CUI-1)
C1706244 (UMLS CUI-2)
C1332051 (UMLS CUI-3)
C1706244 (UMLS CUI-2)
C1332051 (UMLS CUI-3)
Off Study Date
Item
Off Study Date
date
C25164 (NCI Thesaurus ValueDomain)
C25601 (NCI Thesaurus ObjectClass)
C15206 (NCI Thesaurus ObjectClass-2)
C25275 (NCI Thesaurus Property)
C1518544 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
C25601 (NCI Thesaurus ObjectClass)
C15206 (NCI Thesaurus ObjectClass-2)
C25275 (NCI Thesaurus Property)
C1518544 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
Item
Off Study Reason
integer
C25638 (NCI Thesaurus ValueDomain)
C16033 (NCI Thesaurus Property)
C25601 (NCI Thesaurus ObjectClass)
C15206 (NCI Thesaurus ObjectClass-2)
C1522577 (UMLS CUI [1,1])
C1518546 (UMLS CUI [1,2])
C0392360 (UMLS CUI [1,3])
C16033 (NCI Thesaurus Property)
C25601 (NCI Thesaurus ObjectClass)
C15206 (NCI Thesaurus ObjectClass-2)
C1522577 (UMLS CUI [1,1])
C1518546 (UMLS CUI [1,2])
C0392360 (UMLS CUI [1,3])
CL Item
Protocol-defined Follow-up Completed (1)
CL Item
Lost To Follow-up (2)
CL Item
Patient Refused Follow-up (3)
CL Item
Death (4)
CL Item
Adverse Event/side Effects/complications (5)
CL Item
Other (6)
Other, specify
Item
Other, specify
text
C25685 (NCI Thesaurus ValueDomain)
C16033 (NCI Thesaurus Property)
C25601 (NCI Thesaurus ObjectClass)
C15206 (NCI Thesaurus ObjectClass-2)
C1522577 (UMLS CUI [1,1])
C1518546 (UMLS CUI [1,2])
C0392360 (UMLS CUI [1,3])
C16033 (NCI Thesaurus Property)
C25601 (NCI Thesaurus ObjectClass)
C15206 (NCI Thesaurus ObjectClass-2)
C1522577 (UMLS CUI [1,1])
C1518546 (UMLS CUI [1,2])
C0392360 (UMLS CUI [1,3])
Research Comments
Item
Comments
text
C25704 (NCI Thesaurus ValueDomain)
C15319 (NCI Thesaurus ObjectClass)
C25393 (NCI Thesaurus Property)
C0947611 (UMLS CUI [1,1])
C1332051 (UMLS CUI [1,2])
C15319 (NCI Thesaurus ObjectClass)
C25393 (NCI Thesaurus Property)
C0947611 (UMLS CUI [1,1])
C1332051 (UMLS CUI [1,2])